Western diet induces dysbiosis with increased e coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation

Gut

Volumn 63, Issue 1, 2014, Pages 116-124

  Martinez Medina, Margarita ^a,b,c   Denizot, Jérémy ^a,b   Dreux, Nicolas ^a,b   Robin, Frédéric ^a,b,d   Billard, Elisabeth ^a,b,e   Bonnet, Richard ^a,b,d   Darfeuille Michaud, Arlette ^a,b,d,e   Barnich, Nicolas ^a,b,e  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b Inst Natl la Rech Agronom   (France)

^c UNIVERSITY OF GIRONA   (Spain)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e Institut Universitaire de Technologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CASPASE RECRUITMENT DOMAIN PROTEIN 15; MUCIN; TIGHT JUNCTION PROTEIN; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DYSBIOSIS; ESCHERICHIA COLI; FEMALE; FOOD INTAKE; GENE INDUCTION; INFECTION SENSITIVITY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; NOD2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPECIES COMPOSITION; TLR5 GENE;

DIETARY - GASTROINTESTINAL INFECTIONS; GUT INFLAMMATION; IBD BASIC RESEARCH; INTESTINAL BARRIER FUNCTION;

ANIMALS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; COLON; CROHN DISEASE; CYTOKINES; DIET, HIGH-FAT; DIETARY SUCROSE; DYSBIOSIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROBIOTA;

EID: 84889681706     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-304119     Document Type: Article

References (51)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
2. Melgar S, Shanahan F. Inflammatory bowel disease-from mechanisms to treatment strategies. Autoimmunity 2010;43:463-77.
3. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1720-8.
4. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
5. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009;15:653-60.
6. Harper PH, Lee EC, Kettlewell MG, et al. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985;26:279-84. (Pubitemid 15054209)
7. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
8. Andoh A, Imaeda H, Aomatsu T, et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 2011;46:479-86.
9. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007;1:403-18. (Pubitemid 47373247)
10. Erickson AR, Cantarel BL, Lamendella R, et al. Integrated metagenomics/ metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE 2012;7:479.
11. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60:631-7.
12. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 2006;12:1136-45. (Pubitemid 44847471)
13. Prindiville T, Cantrell M, Wilson KH. Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm Bowel Dis 2004;10:824-33. (Pubitemid 39545228)
14. Swidsinski A, Weber J, Loening-Baucke V, et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005;43:3380-9. (Pubitemid 40981351)
15. Fujita H, Eishi Y, Ishige I, et al. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases. J Gastroenterol 2002;37:509-16.
16. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52:237-42. (Pubitemid 36115065)
17. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009;15:1183-9.
18. Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment In Vitro utilization of mucin by other acteria. Am J Gastroenterol 2010;105:2420-8.
19. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21. (Pubitemid 39091889)
20. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93. (Pubitemid 38962277)
21. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis 2009;15:872-82.
22. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 2007;87:1042-54. (Pubitemid 47429187)
23. Chapman-Kiddell CA, Davies PSW, Gillen L, et al. Role of diet in the development of inflammatory bowel disease. Inflamm Bowel Dis 2010;16:137-51.
24. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999;117:73-81. (Pubitemid 29297622)
25. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009;137:1716-24.
26. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.
27. Barnich N, Carvalho F, Glasser A, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007;117:1566-74. (Pubitemid 46871341)
28. Carvalho FA, Barnich N, Sivignon A, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009;206:2179-89.
29. Chan CHF, Stanners CP. Novel mouse model for carcinoembryonic antigen-based therapy. Mol Ther 2004;9:775-85. (Pubitemid 38878124)
30. Denizot J, Sivignon A, Barreau F, et al. Adherent-invasive Escherichia coli induce claudin-2 expression and barrier defect in CEABAC10 mice and crohn's disease patients. Inflamm Bowel Dis 2012:18:294-304.
31. Shibutani M, Uneyama C, Miyazaki K, et al. Methacarn fixation: a novel tool for analysis of gene expressions in paraffin-embedded tissue specimens. Lab Invest 2000;80:199-208. (Pubitemid 30120972)
32. Grootjans J, Hundscheid IHR, Lenaerts K, et al. Ischaemia-induced mucus barrier loss and bacterial penetration are rapidly counteracted by increased goblet cell secretory activity in human and rat colon. Gut 2013;62:250-8.
33. Berrebi D, Maudinas R, Hugot JP, et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003;52:840-6. (Pubitemid 36613491)
34. Lunardi C, Bason C, Dolcino M, et al. Antiflagellin antibodies recognize the autoantigens Toll-Like Receptor 5 and Pals 1-associated tight junction protein and induce monocytes activation and increased intestinal permeability in Crohn's disease. J Intern Med 2009;265:250-65.
35. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010;107:14691-6.
36. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009;9:737-43.
37. Schippa S, Iebba V, Barbato M, et al. A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol 2010;10:175.
38. Servin AL. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev 2005;18:264-92. (Pubitemid 40548294)
39. Kleessen B, Kroesen A, Buhr H, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002;37:1034-41.
40. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54. (Pubitemid 34049193)
41. Kim MS, Choi M-S, Han SN. High fat diet-induced obesity leads to proinflammatory response associated with higher expression of NOD2 protein. Nutr Res Pract 2011;5:219-23.
42. Kim SJ, Choi Y, Choi YH, et al. Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem 2012;23:113-22.
43. Mantis NJ, Rol N, Corthesy B. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 2011;4:603-11.
44. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-82. (Pubitemid 127471570)
45. Ding S, Chi MM, Scull BP, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 2010;5:e12191.
46. Glasser A-L, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001;69:5529-37. (Pubitemid 32786488)
47. Berre NL, Heresbach D, Kerbaol M, et al. Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol 1995;48:749-53.
48. Benjamin J, Makharia GK, Ahuja V, et al. Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease. World J Gastroenterol 2008;14:1399-405. (Pubitemid 351425221)
49. Mankertz J, Amasheh M, Krug S, et al. TNFα up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res 2009;336:67-77.
50. Moehle C, Ackermann N, Langmann T, et al. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 2006;84:1055-66.
51. Kjellev S, Thim L, Pyke C, et al. Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. Dig Dis Sci 2007;52:1050-9. (Pubitemid 46481242)